Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With P… (NCT06244953) | Clinical Trial Compass
RecruitingNot Applicable
Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care
Singapore240 participantsStarted 2024-08-14
Plain-language summary
There is evidence for the effectiveness and feasibility of the individual components of TIER-HF-PC, however there is a need to test how these individual components interact to allow the researchers to deliver TIER-HF-PC as a model of care in its totality. In the short term, this study will assess if TIER-HF-PC is beneficial for patients and caregivers.
Who can participate
Age range
21 Years – 99 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. 21 years or older and
. able to communicate in English/Chinese/Malay and
. be of stage C or D heart failure, as defined by American College of Cardiology/American Heart Association (ACC/AHA) classification system and
. have functional limitation of New York Heart Association (NYHA) functional status of at least 2 or more and
. be deemed by their cardiologist's clinical judgement to have an expected prognosis of at least 6 months survival, and
. have had a heart failure related hospitalization event (e.g. symptomatic decompensated heart failure) within 6 months prior to recruitment and
. have a phone that allows telecommunication.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Patient quality of life (QOL) per the KCCQ-12 Questionnaire
Timeframe: Every 8 weeks from baseline, till the point of patient death, or till week 48, whichever is earlier.
2
Patient quality of life (QOL) per the EUROQOL EQ-5D-5L Questionnaire
Timeframe: Baseline, 8 weeks, 16 weeks, and 24 weeks.
3
Caregiver Quality of Life (QOL)
Timeframe: Every 8 weeks from baseline, till the point of patient death, or till week 48, whichever is earlier.